Investigation of amyloid pathology mechanisms and prediction of clinical trial results using QSP model

NEWS
Conference
November 6, 2018

November 6, 2018

InSysBio presents the video of Tatiana Karelina’s talk in framework of session “From translational PKPD models to quantitative system pharmacology in neurodegeneration drug development” at the 9th American Conference on Pharmacometrics (ACoP9):

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

September 2021
MoTuWeThFrSaSu
  
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
1. 23 Sep 2021 16:14 InSysBio to participate in SITC 2021 InSysBio announces its participation in SITC's 36th Annual Meeting & Pre-Conference Programs (the Society for Immunotherapy of Cancer) which to be held November 10th to 14th, 2021 in person in Washington, DC, and virtually. InSysBio expert modeler Oleg Demin Jr and his student Elena Vasileva are going to present a poster
24
25
26
27
28
29
30
   
Upcoming Events
Tags
Latest News
15.05
15th InSysBio’s Annual Internal Scientific Meeting
09.04
InSysBio to release a new version of LikelihoodProfiler.jl
31.03
InSysBio to launch Immune Response Template version 3.7.0 for QSP modeling
19.03
InSysBio announces its collaboration with discoveric bio alpha
19.02
InSysBio to publish the new article in CPT: Pharmacometrics & Systems Pharmacology